These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1056012)

  • 21. Effect of prostaglandins on bradykinin-induced visceral-cardiac reflexes.
    Stebbins CL; Smith RC; Longhurst JC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H155-63. PubMed ID: 3893162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary vasodilation: interactions between prostacyclin and adenosine.
    Blass KE; Förster W; Zehl U
    Br J Pharmacol; 1980 Aug; 69(4):555-9. PubMed ID: 7002243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
    Fulton D; McGiff JC; Wolin MS; Kaminski P; Quilley J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):702-9. PubMed ID: 9023282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of prostaglandins in renal sensory receptor activation by substance P and bradykinin.
    Kopp UC; Smith LA
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R544-51. PubMed ID: 7692751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of bradykinin and the ischemic isolated rat heart.
    Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H
    Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oxygen tension on flow-induced vasodilation in porcine coronary resistance arterioles.
    Jimenez AH; Tanner MA; Caldwell WM; Myers PR
    Microvasc Res; 1996 May; 51(3):365-77. PubMed ID: 8992234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of brefeldin A, a membrane transport blocker, on the bradykinin-induced hyperpolarization-mediated relaxation in the porcine coronary artery.
    Ohnishi Y; Hirano K; Nishimura J; Furue M; Kanaide H
    Br J Pharmacol; 2001 Sep; 134(1):168-78. PubMed ID: 11522609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney.
    Nishikawa K; Morrison A; Needleman P
    J Clin Invest; 1977 Jun; 59(6):1143-50. PubMed ID: 864006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg9bradykinin-induced coronary vasodilation.
    McLean PG; Perretti M; Ahluwalia A
    Br J Pharmacol; 1999 Sep; 128(2):275-82. PubMed ID: 10510436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect.
    Lembeck F; Popper H; Juan H
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):69-73. PubMed ID: 1004630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.
    Needleman P; Bronson SD; Wyche A; Sivakoff M; Nicolaou KC
    J Clin Invest; 1978 Mar; 61(3):839-49. PubMed ID: 346605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: the concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin.
    Ferreira SH; Moncada S; Parsons M; Vane JR
    Br J Pharmacol; 1974 Sep; 52(1):108P-109P. PubMed ID: 4451769
    [No Abstract]   [Full Text] [Related]  

  • 33. The actions of bradykinin and eledoisin in the canine isolated kidney: relationships to prostaglandins.
    McGiff JC; Itskovitz HD; Terragno NA
    Clin Sci Mol Med; 1975 Aug; 49(2):125-31. PubMed ID: 1149403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac effects of essential phospholipids and prostaglandin release by the heart in the rat].
    Smirnov IE; Ziabkina AG; Markov KhM
    Kardiologiia; 1984 Apr; 24(4):99-104. PubMed ID: 6233448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus.
    Szerafin T; Erdei N; Fülöp T; Pasztor ET; Edes I; Koller A; Bagi Z
    Circ Res; 2006 Sep; 99(5):e12-7. PubMed ID: 16917094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wound healing following myocardial infarction in the rat: role for bradykinin and prostaglandins.
    Frimm Cde C; Sun Y; Weber KT
    J Mol Cell Cardiol; 1996 Jun; 28(6):1279-85. PubMed ID: 8782069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological modification of the edema produced by combined infusions of prostaglandin E1 and bradykinin in canine forelimbs.
    Prasad CM; Adamski SW; Svensjö E; Grega GJ
    J Pharmacol Exp Ther; 1982 Feb; 220(2):293-8. PubMed ID: 6173476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
    Schrör K; Link HB; Rösen R; Klaus W; Rösen P
    Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia.
    Bogle RG; McLean PG; Ahluwalia A; Vallance P
    Br J Pharmacol; 2000 May; 130(1):118-24. PubMed ID: 10781006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.